AzTrials
AzTrials

AnesthesiaNCT02663843

Low Skill Fibreoptic Intubation I-gel vs Air-Q

A study testing i-gel airway and air-Q airway in people with Anesthesia, run by Singapore General Hospital at 1 site in Singapore.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Tracheal intubation under general anaesthesia is the gold standard for securing the airway and for protecting the lungs against gastric aspiration. The conventional technique involves the use of a metal laryngoscope inserted into the mouth to create an air space, to allow insertion of an endotracheal tube. Read more about this study

Who is it for?
Ages 21 to 80 years
Conditions the study is for
Anesthesia
What is being tested?
i-gel airway and air-Q airway
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSingapore
Study dates
1 Jan 2017to 1 Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with a physical status of American Society of Anesthesiologists (ASA) grade I/II and over 21 years old, having elective surgery, who require endotracheal intubation

Who cannot join

  • ASA class III/IV
  • Patients with history of previous difficult endotracheal intubation
  • Patients with two or more predictors of difficult airway management (criteria 1-8, below)
  • Airway masses
  • Mallampati (oropharygneal space grading) III or IV
  • Thyromental distance < 6.5cm
Show all 13Show fewer
  • Inter-incisor distance < 3 cm
  • Head extension < 30 degrees
  • Edentulous
  • Large beard
  • Obstructive sleep apnoea (OSA) or snorer
  • Patients needing a rapid sequence induction
  • Pregnant women

Trial locations and contacts

1 site in 1 country.

Patrick Wong, MBBS FRCA contact

+6563214220

Patrick.Wong@singhealth.com.sg

Hairil RB Abdullah, MBBS MMED contact

+6563214220

hairil.rizal.abdullah@singhealth.com.sg

Singapore1 site, 1 recruiting
  • Singapore General Hospitals

    Singapore, 169608

    Patrick Wong, FRCA, 63214220, patrick.wong@singhealth.com.sg

    Recruiting

Other trials in Singapore

About this study

Official title: Comparison of 'Low Skill Fibreoptic Tracheal Intubation' Via I-gel® and Air-Q® Supraglottic Airway Devices in Patients With Simulated Difficult Airways.

Tracheal intubation under general anaesthesia is the gold standard for securing the airway and for protecting the lungs against gastric aspiration. The conventional technique involves the use of a metal laryngoscope inserted into the mouth to create an air space, to allow insertion of an endotracheal tube.

Alternatively, an oral airway device (called a supraglottic device (SGD)) can be used for tracheal intubation. The SGD is first inserted. A fibrescope is inserted down the shaft of the SGD and into the trachea. This allows an endotracheal tube (previously pre-loaded onto the fibrescope) to be railroaded of the fibrescope and into the trachea. This technique is called 'low skill fibreoptic intubation' as the SGD acts as a guide for the fibrescope. Our study compares the performance of two SGD: i-gel and air-Q. The investigators will compare intubation success rate, insertion rate, and times for SGD insertion and intubation.

Read the detailed description

The investigators are testing to see if fibreoptic intubation in patients via a supraglottic airway device i.e. 'low skill fibreoptic intubation' (LSFOI) is more successful via the i-gel® than in the air-Q®. Patients are those scheduled for elective surgery under general anaesthesia who would normally require tracheal intubation. The investigator's hypothesis is based on the results of the investigator's recent manikin study (CIRB 2014/2039). The investigators would like to see if this hypothesis translates to patients. It will also test secondary outcomes e.g. SGD insertion success rates and times, and intubation times. In the aforementioned manikin study, the air-Q® performed better with the SGD insertion rates and times. However, the i-gel® performed better with intubation success rates and times. The devices may perform different due to differences between the devices: design (shape, volume, length, aperture), material composition, and technique required for insertion and intubation.

24 adult patients undergoing elective surgery requiring general anaesthesia and endotracheal intubation in the major operating theater of Singapore General Hospital will be enrolled. The patient will then be randomised in equal proportions into two groups, either the air-Q® or i-gel®. Patients will undergo induction of general anaesthesia in a standardised fashion and in accordance with usual practice in the investigator's department of anaesthesia. Intubation will then proceed with the assigned airway device. Data collected will include successful endotracheal intubation, as evidenced by the presence of end tidal carbon dioxide on a capnograph. Time to intubation (from the initial handling of the airway device until successful intubation is confirmed with successful lung ventilation), the number of attempts required and the view achieved (according to the modified Cormack and Lehane scoring system) will also be recorded. Injuries to the lips, teeth or upper airway will be sought and documented by a blinded observer in the Post Anesthetic Care Unit.

A protocol will be provided to standardise the induction of general anaesthesia. This will involve the application of standard patient monitors, a period of pre-oxygenation, and administration of anaesthetic agents and muscle relaxants. If the patient desaturates to SpO2 < 94% during intubation, the intubation attempt via either the air-Q® or i-gel® will be abandoned and intubation will proceed using the conventional direct laryngoscope.

Conditions
Anesthesia
Being tested
i-gel airway, air-Q airway

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • i-gel airwayDevice

    Fibreoptic intubation via i-gel airway device

  • air-Q airwayDevice

    Fibreoptic intubation via air-Q airway device

Study groups in NCT02663843
Study groupRoleWhat they receive
i-gel airwayExperimentalI-gel inserted for the low skill fibreoptic intubation technique
Receives: Device: i-gel airway
air-Q airwayExperimentalAir-Q inserted for the low skill fibreoptic intubation technique
Receives: Device: air-Q airway

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success of low skill fibreoptic intubation using the i-gel or air-Q airway devices measured end tidal carbon dioxide levels

    Successful intubation indicated by normal end tidal carbon dioxide levels and trace

    Measured: 3 minutes

Secondary outcomes (3)
  1. Airway device insertion times

    Time from picking up device to obtaining adequate canpography tracing

    Measured: 3 minutes

  2. Low skill fibreoptic intubation times

    Time from picking up fibrescope to obtaining adequate canpography tracing

    Measured: 3 minutes

  3. Complication rate

    Complications due to airway and fiberscope insertion and use

    Measured: Time of intubation and up to one day postoperative recovery period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2016 (estimated)
  2. Study start1 Jan 2017
  3. Primary completion1 Jun 2017 (estimated)
  4. Study completion1 Jun 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02663843
Sponsor's protocol ID
1601LSFOI
Status last verified
Apr 2017
First submitted
18 Jan 2016
Last updated
1 May 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • de Lloyd LJ, Subash F, Wilkes AR, Hodzovic I. A comparison of fibreoptic-guided tracheal intubation through the Ambu (R) Aura-i , the intubating laryngeal mask airway and the i-gel : a manikin study. Anaesthesia. 2015 May;70(5):591-7. doi: 10.1111/anae.12988. Epub 2015 Jan 29.

    PubMed 25631299
  • Galgon RE, Schroeder KM, Han S, Andrei A, Joffe AM. The air-Q((R)) intubating laryngeal airway vs the LMA-ProSeal(TM) : a prospective, randomised trial of airway seal pressure. Anaesthesia. 2011 Dec;66(12):1093-100. doi: 10.1111/j.1365-2044.2011.06863.x. Epub 2011 Aug 22.

    PubMed 21880031
  • Moon HS, Lee JY, Chon JY, Lee H, Kim D. Air-Q(R)sp-assisted awake fiberoptic bronchoscopic intubation in a patient with Ludwig's angina. Korean J Anesthesiol. 2014 Dec;67(Suppl):S23-4. doi: 10.4097/kjae.2014.67.S.S23. No abstract available.

    PubMed 25598892

Questions about this trial

What is this clinical trial studying?

A study testing i-gel airway and air-Q airway in people with Anesthesia, run by Singapore General Hospital at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Patrick Wong, MBBS FRCA (+6563214220, Patrick.Wong@singhealth.com.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success of low skill fibreoptic intubation using the i-gel or air-Q airway devices measured end tidal carbon dioxide levels (time frame: 3 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02663843, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in